Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1450691
European Journal of Endocrinology, Vol 145, Issue 6, 691-696
Copyright © 2001 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petretta, M
Right arrow Articles by Lupoli, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petretta, M
Right arrow Articles by Lupoli, G
Articles

Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism

M Petretta, D Bonaduce, L Spinelli, ML Vicario, V Nuzzo, F Marciano, P Camuso, V De Sanctis, and G Lupoli

Department of Internal Medicine, Cardiology and Heart Surgery, Federico II University of Naples, Naples, Italy.

OBJECTIVE: To characterize cardiac structure and function and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. DESIGN: Thirty patients with subclinical hyperthyroidism and 30 with overt disease were selected from patients never previously treated for endocrinological disease in the outpatient clinic of our institution. Twenty normal individuals were studied as control group. METHODS: Left ventricular structure and function and cardiac autonomic control were evaluated, respectively, by two-dimensional Doppler echocardiography and by 24-h Holter recording with heart rate variability analysis. RESULTS: Patients with overt hyperthyroidism showed greater values of left ventricular end-diastolic volume (P<0.05) and left ventricular mass (P<0.05) than patients with subclinical disease. In addition, the mean velocity of left ventricular fibre shortening (P<0.05) and left ventricular ejection fraction (P<0.05) were greater in patients with overt hyperthyroidism than in patients with subclinical disease. No difference in any of these parameters was detectable between normal subjects and patients with subclinical disease. The isovolumic relaxation period was shorter in patients with subclinical hyperthyroidism than in control individuals (P<0.05) and in patients with overt hyperthyroidism (P<0.05). As regards cardiac autonomic control, all time and frequency domain measures decreased progressively from control individuals to patients with subclinical hyperthyroidism and those with overt disease (P<0.001). CONCLUSIONS: Thyrotoxic patients show changes in left ventricular structure and increased echocardiographic indexes of myocardial contractility, whereas the only echocardiographic feature detectable in patients with subclinical hyperthyroidism is an increased velocity of left ventricular relaxation. Cardiac parasympathetic withdrawal is evident in patients with overt hyperthyroidism and in patients with subclinical disease.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. F. A. Eustatia-Rutten, E. P. M. Corssmit, K. A. Heemstra, J. W. A. Smit, R. C. Schoemaker, J. A. Romijn, and J. Burggraaf
Autonomic Nervous System Function in Chronic Exogenous Subclinical Thyrotoxicosis and the Effect of Restoring Euthyroidism
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2835 - 2841.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Cooper
Approach to the Patient with Subclinical Hyperthyroidism
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 3 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Casu, C. Cappi, V. Patrone, E. Repetto, M. Giusti, F. Minuto, and G. Murialdo
Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer
Eur. J. Endocrinol., June 1, 2005; 152(6): 819 - 824.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
F Azizi, L Ataie, M Hedayati, Y Mehrabi, and F Sheikholeslami
Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine
Eur. J. Endocrinol., May 1, 2005; 152(5): 695 - 701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Dorr, B. Wolff, D. M. Robinson, U. John, J. Ludemann, W. Meng, S. B. Felix, and H. Volzke
The Association of Thyroid Function with Cardiac Mass and Left Ventricular Hypertrophy
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 673 - 677.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi
Subclinical hyperthyroidism: clinical features and treatment options
Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. E. Weiss, C. Korcarz, O. Chassande, K. Cua, P. M. Sadow, E. Koo, J. Samarut, and R. Lang
Thyroid hormone and cardiac function in mice deficient in thyroid hormone receptor-alpha or -beta : an echocardiograph study
Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E428 - E435.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 European Society of Endocrinology.